TAK-875
TAK-875_304
Phase 3 small_molecule terminated
Quick answer
TAK-875 for Diabetes Mellitus, Type 2 is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 4 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Diabetes Mellitus, Type 2
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated